List of SBIR/STTR awards granted to GLYCOSENSORS AND DIAGNOSTICS, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in March, 2020 for $740,575.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44OD024964-02 | Phase II | 740,575 | March 1, 2020 | |||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in September, 2018 for $224,934.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44OD024964-01 | Phase I | 224,934 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in March, 2020 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM135984-01 | Phase I | 225,000 | March 1, 2020 | |||||||
A SBIR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in January, 2018 for $699,912.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM113351-03 | Phase II | 699,912 | January 15, 2018 | |||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in March, 2020 for $224,996.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM136013-01 | Phase I | 224,996 | March 1, 2020 | |||||||
A STTR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in September, 2013 for $1,728,189.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42GM086991-02A1 | Phase II | 1,728,189 | September 20, 2013 | |||||||
A STTR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in January, 2015 for $698,157.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41GM113351-01 | Phase I | 698,157 | January 15, 2015 | |||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in September, 2017 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123863-01 | Phase I | 300,000 | September 19, 2017 | |||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in August, 2017 for $504,888.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123856-01A1 | Phase I | 504,888 | August 1, 2017 | |||||||
A STTR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC for $1,462,149.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42GM086991-02A1 | Phase II | 1,462,149 | ||||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC for $99,968.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM100621-01 | Phase I | 99,968 | ||||||||
A STTR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC for $200,361.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41GM086991-01A1 | Phase I | 200,361 | ||||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC for $148,851.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110079 | Phase I | 148,851 | ||||||||
A SBIR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC for $999,970.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CA130048 | Phase II | 999,970 | ||||||||
A SBIR Phase I contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in August, 2023 for $301,703.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44OD035390-01A1 | Phase I | 301,703 | August 1, 2023 | |||||||
A SBIR Phase II contract was awarded to GLYCOSENSORS AND DIAGNOSTICS, LLC in September, 2023 for $988,601.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM153145-01 | Phase II | 988,601 | September 15, 2023 |
